• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Atopic Dermatitis Control Tool (ADCT): A useful tool for self-evaluation in patients with atopic dermatitis.

作者信息

Kido-Nakahara Makiko, Yokote Ginju, Yoshida Maiko, Furue Masutaka, Nakahara Takeshi

机构信息

Department of Dermatology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.

Research and Clinical Center for Yusho and Dioxin, Kyushu University Hospital, Fukuoka, Japan.

出版信息

J Dermatol. 2021 Dec;48(12):1951-1952. doi: 10.1111/1346-8138.16176. Epub 2021 Sep 27.

DOI:10.1111/1346-8138.16176
PMID:34580905
Abstract
摘要

相似文献

1
Atopic Dermatitis Control Tool (ADCT): A useful tool for self-evaluation in patients with atopic dermatitis.特应性皮炎控制工具（ADCT）：一种用于特应性皮炎患者自我评估的有用工具。
J Dermatol. 2021 Dec;48(12):1951-1952. doi: 10.1111/1346-8138.16176. Epub 2021 Sep 27.
2
Validation of five patient-reported outcomes for atopic dermatitis severity in adults.五项成人特应性皮炎严重程度患者报告结局的验证
Br J Dermatol. 2020 Jan;182(1):104-111. doi: 10.1111/bjd.18002. Epub 2019 Jul 24.
3
Comparison of Patient-Oriented Eczema Measure and Patient-Oriented Scoring Atopic Dermatitis vs Eczema Area and Severity Index and other measures of atopic dermatitis: A validation study.患者导向湿疹量表与患者导向特应性皮炎评分与湿疹面积和严重程度指数及其他特应性皮炎衡量指标的比较：验证研究。
Ann Allergy Asthma Immunol. 2020 Jul;125(1):78-83. doi: 10.1016/j.anai.2020.03.006. Epub 2020 Mar 18.
4
The Atopic Dermatitis Control Tool: A High-Performance Tool for Optimal Support.特应性皮炎控制工具：优化支持的高性能工具。
Acta Derm Venereol. 2021 Dec 13;101(12):adv00618. doi: 10.2340/actadv.v101.750.
5
Spanish Version of the RECAP Questionnaire to Assess Control of Atopic Eczema: Translation, Cultural Adaptation, Validation, and Correlations with Other Patient-Reported Outcome Measures.《特应性皮炎控制评估问卷》西班牙语版的评估：翻译、文化调适、验证及与其他患者报告结局测量的相关性。
6
Measuring Atopic Eczema Control and Itch Intensity in Clinical Practice: A Consensus Statement From the Harmonising Outcome Measures for Eczema in Clinical Practice (HOME-CP) Initiative.临床实践中特应性皮炎控制情况及瘙痒强度的测量：临床实践中湿疹统一结局测量（HOME-CP）倡议的共识声明
JAMA Dermatol. 2022 Dec 1;158(12):1429-1435. doi: 10.1001/jamadermatol.2022.4211.
7
The HOME Core outcome set for clinical trials of atopic dermatitis.特应性皮炎临床试验的 HOME 核心结局集。
J Allergy Clin Immunol. 2022 Jun;149(6):1899-1911. doi: 10.1016/j.jaci.2022.03.017. Epub 2022 Mar 26.
8
Approach to the Assessment and Management of Adult Patients With Atopic Dermatitis: A Consensus Document. Section II: Tools for Assessing the Severity of Atopic Dermatitis.成人特应性皮炎评估与管理方法：共识文件。第二部分：特应性皮炎严重程度评估工具
J Cutan Med Surg. 2018 Nov/Dec;22(1_suppl):10S-16S. doi: 10.1177/1203475418803628.
9
Eczema control and treatment satisfaction in atopic dermatitis patients treated with dupilumab - a cross-sectional study from the BioDay registry.特应性皮炎患者接受度普利尤单抗治疗的湿疹控制和治疗满意度 - 来自 BioDay 登记的一项横断面研究。
J Dermatolog Treat. 2022 Jun;33(4):1986-1989. doi: 10.1080/09546634.2021.1937485. Epub 2021 Jun 21.
10
Evaluating patient-perceived control of atopic dermatitis: design, validation, and scoring of the Atopic Dermatitis Control Tool (ADCT).评估特应性皮炎患者的自我控制感：特应性皮炎控制工具（ADCT）的设计、验证和评分。
Curr Med Res Opin. 2020 Mar;36(3):367-376. doi: 10.1080/03007995.2019.1699516. Epub 2019 Dec 12.

引用本文的文献

1
Recurrence and influencing factors of moderate-to-severe atopic dermatitis after dupilumab withdrawal: a retrospective cohort analysis.度普利尤单抗停药后中重度特应性皮炎的复发及影响因素：一项回顾性队列分析
Front Med (Lausanne). 2025 Aug 13;12:1585368. doi: 10.3389/fmed.2025.1585368. eCollection 2025.
2
Utility of the Atopic Dermatitis Control Tool for Assessing Long-term Control of Atopic Dermatitis in Korean Patients on Dupilumab.特应性皮炎控制工具在评估接受度普利尤单抗治疗的韩国特应性皮炎患者长期病情控制方面的效用
Allergy Asthma Immunol Res. 2025 Jul;17(4):519-526. doi: 10.4168/aair.2025.17.4.519.
3
Validation of the Atopic Dermatitis Control Tool (ADCT) and a Comparison with the Recap of Atopic Eczema Questionnaire (RECAP).
特应性皮炎控制工具（ADCT）的验证及与特应性湿疹问卷摘要（RECAP）的比较。
Acta Derm Venereol. 2025 Feb 18;105:adv42364. doi: 10.2340/actadv.v105.42364.
4
Evaluating the Real-World Effectiveness of Systemic Treatments in Atopic Dermatitis Using the Atopic Dermatitis Control Tool (ADCT): A Multi-Centre, Prospective Study.使用特应性皮炎控制工具（ADCT）评估系统性治疗在特应性皮炎中的真实世界有效性：一项多中心前瞻性研究。
Acta Derm Venereol. 2025 Feb 12;105:adv40704. doi: 10.2340/actadv.v105.40704.
5
Atopic Dermatitis Patients' Preference on Patient Self-administered Tools Used in Clinical Practice.特应性皮炎患者对临床实践中患者自行使用工具的偏好
Acta Derm Venereol. 2023 Apr 6;103:adv5261. doi: 10.2340/actadv.v103.5261.